2024 | BioSenic

Medsenic, subsidiary of BioSenic SA, extends key patent to the United States

Read more about Medsenic, subsidiary of BioSenic SA, extends key patent to the United States

Medsenic, filiale de BioSenic SA, étend un brevet clé aux États-Unis

Read more about Medsenic, filiale de BioSenic SA, étend un brevet clé aux États-Unis

Nouveaux accords de licence et de commercialisation avec Phebra PTY Ltd

Read more about Nouveaux accords de licence et de commercialisation avec Phebra PTY Ltd

New set of licensing and commercialization agreements with Phebra PTY Ltd

Read more about New set of licensing and commercialization agreements with Phebra PTY Ltd

June 2024 Denominator

Read more about June 2024 Denominator

Denominateur de Juin 2024

Read more about Denominateur de Juin 2024

BioSenic signe une nouvelle convention de souscription pour un maximum de 2,1 millions d'euros en obligations convertibles

Read more about BioSenic signe une nouvelle convention de souscription pour un maximum de 2,1 millions d'euros en obligations convertibles

BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in convertible bonds

Read more about BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in convertible bonds

The Enterprise Court of Nivelles approval

Read more about The Enterprise Court of Nivelles approval

The approval of the Nivelles Commercial Court

Read more about The approval of the Nivelles Commercial Court

Subscribe to 2024